About 8 to 10 million Americans over age 40 have an overabundance of cloned white blood cells, or lymphocytes, that hamper their immune systems. Although many who have this condition - called ...

LC-MBL is associated with a 92% increased risk of melanoma, similar to the risk in CLL patients. MBL is prevalent in 5% to 12% of the US population over 40, impacting melanoma rates. Study ...

Current treatment options have been limited to symptom control. Telitacicept, a novel fusion protein, and ianalumab, a monoclonal antibody, demonstrate improvement in disease activity.

STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors Using the Mayo Clinic Biobank, we ...

CLL is the most common leukemia in adults in Western countries, with a male predominance and an average age at diagnosis of 72 years. The disease is characterized by an accumulation of monoclonal, ...

Non-Hodgkin's lymphoma is a group of cancers that start in lymphocytes -- your immune system’s infection-fighting white blood cells. Doctors divide it into types based on the kind of lymphocyte each ...